Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Comparison of Two Pulmonary Embolism Treatments

← catalyst calendar

NCT05684796 · results posted

Sponsored by Penumbra Inc. (industry) · PEN — their whole pipeline →.

Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
100actual
Sites
22
Countries
Canada, New Zealand, Poland +1

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-11-27actualWhen the study began enrolling
Primary completion2025-06-12actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-09-09actualThe whole study's end, after follow-up
First posted2023-01-13actualWhen this record first appeared on the registry
Results posted2026-08-18actualWhen the sponsor posted results to the registry
Record updated2026-08-18actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Pulmonary Embolism Acute

Interventions

  • Drug: Anticoagulation
  • Device: mechanical aspiration thrombectomy — also filed as Indigo Aspiration System

Primary outcome

what the primary-completion date above is the date OF
Change in RV/LV Ratio
measured 48 hours post-randomization

Posted documents

hosted by the registry — we link, never re-serve
Study Protocol and Statistical Analysis Planposted 2024-12-16 · 1.4 MB · Prot_SAP_000.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · PEN's whole pipeline · Catalyst calendar · Every registered study · What changed